Mithra Pharmaceuticals S.A. (Euronext: MITRA)

https://www.mithra.com

LinkedIn: https://www.linkedin.com/company/mithra-pharmaceutical

Mithra Pharmaceuticals SA (Euronext: MITRA) is a Belgian biopharmaceutical company dedicated to transforming Women’s Health by offering new choices through innovation, with a particular focus on contraception and menopause. Mithra’s goal is to develop products offering better efficacy, safety and convenience, meeting women’s needs throughout their life span. Mithra explores the potential of the unique native estrogen estetrol in a wide range of applications in women health and beyond. After having successfully launched the first estetrol-based product in 2021, the contraceptive pill Estelle®, Mithra is now focusing on its second product Donesta®, the next-generation hormone therapy. Mithra also offers partners a complete spectrum of solutions from early drug development, clinical batches and commercial manufacturing of complex polymeric products (vaginal ring, implants) and complex liquid injectables and biologicals (vials, pre-filled syringes or cartridges) at its technological platform Mithra CDMO. Active in more than 100 countries around the world, is headquartered in Liège, Belgium. *

	Start	2021-03-05 existent
	Group	Mithra Pharmaceuticals (Group)
	Industry	women’s health
	Industry 2	contraceptive
	Person	Solomon, David Horn (Mithra Pharmaceuticals 202304– before Pharnext+ Silence Tx + Zealand Pharma + Bionor Pharma)
	Person 2	Homsy, Christian (Celyad 201904– Non-executive Board Director before CEO of Celyad / Cardio3 BioSciences since 2007)

	Region	Liège (Lüttich)
	Country	Belgium
	Street	5/6 Rue St-Georges
	City	4000 Liège
	Tel	+32-4-349-2822
		Address record changed: 2024-01-05

Basic data	Employees	D: 101 to 500 (2022-12-31)
	Currency	EUR
	Annual sales	66,997,000 (revenue, annual, consolidated (2022) 2022-12-31)
	Profit	-59,620,000 (2022-12-31)
	Cash	28,285,000 (2022-12-31)

		* Document for »About Section«: Mithra Pharmaceuticals S.A.. (5/29/23). "Press Release: Mithra Appoints Experienced Life Sciences Executive Christian Homsy as Chairman". Liège.

		Record changed: 2024-02-12